Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Clinical trial NCT06072612 · RECRUITING

Trial details

NCT number: NCT06072612
Sponsor: BriaCell Therapeutics Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Breast Neoplasm Breast Cancer Metastatic End Stage Cancer

Start date: 2023-12-05
Primary completion: 2027-12-01
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.